Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
November 12, 2019 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
September 17, 2019 CT ORDER

CT ORDER

View HTML
September 11, 2019 8-K

Report of unscheduled material events or corporate event

View HTML
September 4, 2019 4

Statement of changes in beneficial ownership of securities

View HTML
August 8, 2019 8-K

Report of unscheduled material events or corporate event

View HTML
August 8, 2019 10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
August 8, 2019 S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
August 5, 2019 3

Initial filing by director officer or owner of more than ten percent.

View HTML
June 11, 2019 8-K

Report of unscheduled material events or corporate event

View HTML
June 10, 2019 4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us